Researchers at the RIKEN Global Research Cluster in Japan have discovered a way to prevent the spread of cancer in the liver. Published in the journal Cell Chemical Biology, the study details how treatment with a modified ...
Oct 12, 2017
0
1
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.
Sep 22, 2017
0
153
For several years, medical researchers, doctors and dieticians have known that a low carbohydrate diet and plentiful fat can prevent a range of lifestyle and age-related diseases and thus promote healthy aging. But researchers ...
Sep 15, 2017
0
56
One of the goals of personalized medicine is to be able to determine which treatment would work best by sequencing a patient's genome. New research from the lab of Yimon Aye, assistant professor of chemistry and chemical ...
Aug 1, 2017
0
38
A team of researchers at McMaster University has identified a unique feature of cancer stem cells that can be exploited to kill the deadly cells thought to be the reason that cancer comes back after therapy. Understanding ...
Jun 22, 2017
0
5
Cleveland Clinic researchers have shown for the first time how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change depending on how they are metabolized. Their ...
Jun 22, 2017
0
2
Around 1% of patients with HIV - known as elite controllers - are able to survive without antiviral treatment, because their immune systems produce certain kinds of HIV-specific antibodies: proteins that recognise features ...
May 25, 2017
0
2
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new drug delivery method that produces strong results in treating cancers in animal models, including some hard-to-treat solid and ...
Mar 16, 2017
0
0
Hedgehog (HH) signaling plays an important role in certain types of adult stem cells and cancer stem cells. Its aberrant activity is linked to degenerative diseases and a multitude of cancers.
Mar 10, 2017
0
0
Research led by Associate Professor David Ackerley, director of Victoria's Biotechnology programme, has underpinned the development of a new form of chemotherapy that exclusively targets cancer cells.
Mar 3, 2017
0
4
